Krx Aesthetics Biophase Molecular Night Peel

Manufacturer
KRX RESOURCES SDN. BHD.
Effective date
2025-10-18
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 01:39:31

Label at a glance#

ProductKrx Aesthetics Biophase Molecular Night Peel
Active ingredientSALICYLOYL PHYTOSPHINGOSINE, GLUCONOLACTONE
Label structure8 sections

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

Dosage and Administration

  • For topical use only.
  • Apply evenly to clean, dry skin at night, avoiding the eye and lip areas.
  • Use 1–2 times per week or as directed by a skincare professional.
  • Do not rinse off immediately; leave on overnight unless irritation occurs.
  • Begin with less frequent use to assess tolerance, especially for sensitive skin.
  • Always apply a broad-spectrum sunscreen during the day when using this product.
  • Do not apply on broken, inflamed, or compromised skin.

WARNINGS SECTION

For external use only.

Avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.

Do not apply to broken, irritated, or inflamed skin.

A mild tingling or redness may occur. If severe irritation develops, discontinue use and consult a healthcare professional.

Use sunscreen and limit sun exposure while using this product, as it may increase skin sensitivity to the sun.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

INACTIVE INGREDIENT SECTION

Water

Butylene Glycol

Niacinamide

Panthenol

Dipropylene Glycol

Pentylene Glycol

Betaine

Sodium Citrate

Hydroxyacetophenone

Allantoin

Biosaccharide Gum-1

Sodium Hyaluronate

Ethylhexylglycerin

Caprylyl Glycol

1,2-Hexanediol

Phenoxyethanol

Chlorphenesin

Fragrance

INDICATIONS & USAGE SECTION

Indications and Usage

  • KrX Aesthetics Biophase Molecular Night Peel (PHA/LHA) is indicated for topical use as an exfoliating treatment.
  • Helps gently resurface the skin to improve texture, clarity, and brightness.
  • Aids in the removal of dead skin cells while promoting a smoother, more radiant complexion.
  • Recommended for use at night as part of a skincare regimen.
  • Not intended for use on broken or inflamed skin.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of children

OTC - PURPOSE SECTION

Exfoliant / Skin Resurfacing

Brightening & Smoothing

OTC - ACTIVE INGREDIENT SECTION

Gluconolactone (PHA)

Salicyloyl Phytosphingosine (LHA)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Content of labelingContent of labelingProduct labeling

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GLUCONOLACTONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d1c9d1af-bddd-448d-86f7-69052b7d5b47Product name120220627
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84755-0005-1Krx Aesthetics Biophase Molecular Night Peel2 U in 1 BOTTLECREAM23

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84755-000584755-0005-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Krx Aesthetics Biophase Molecular Night PeelKRX AESTHETICS BIOPHASE MOLECULAR NIGHT PEELKRX RESOURCES SDN. BHD.3dd69bcb-3743-eb01-e063-6394a90ab7e02025-10-18WarningsExact identifier
ndc (package): 84755-0005-1
ndc (product): 84755-0005
ndc11 (package): 84755000501
spl id: 4173475d-c016-8ad3-e063-6394a90ad772
spl set id: 3dd69bcb-3743-eb01-e063-6394a90ab7e0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.